Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 99,120	$ 60,649
Marketable securities	259,172	302,301
Interest receivable	2,447	1,375
Prepaid assets	4,192	3,399
Prepaid clinical	11,505	6,413
Assets held for sale	19,368	0
Other current assets	80	9
Total Current Assets	395,884	374,146
Fixed assets, net	42,222	42,143
Right of use assets, net	2,967	4,263
Total assets	441,073	420,552
Current liabilities
Accounts payable	3,633	5,098
Lease liabilities	765	803
Accrued expenses and other	31,137	17,665
Income taxes payable	682	1,472
Total current liabilities	36,217	25,038
Income tax payable, net of current portion	748	568
Lease liabilities, net of current portion	2,471	3,610
Total liabilities	39,436	29,216
Commitments and Contingencies
Redeemable noncontrolling interest	1,396,591	1,494,732
Shareholders' deficit / members' equity:
Additional paid-in capital	205,736	36,114
Accumulated other comprehensive gain	130	130
Accumulated deficit	(1,200,849)	(1,139,663)
Total shareholders' deficit	(994,954)	(1,103,396)
Total liabilities and shareholders' deficit	441,073	420,552
Common Class A [Member]
Shareholders' deficit / members' equity:
Common stock value	13	6
Common Class B [Member]
Shareholders' deficit / members' equity:
Common stock value	$ 16	$ 17